158 related articles for article (PubMed ID: 8139147)
21. Urinary fibrinogen degradation products and differential protein clearances in renal disease.
Blainey JD; Terry JM
Clin Nephrol; 1979 Mar; 11(3):140-1. PubMed ID: 436342
[TBL] [Abstract][Full Text] [Related]
22. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K; Hewitson TD; Kincaid-Smith P
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[TBL] [Abstract][Full Text] [Related]
23. Urinary fibrin (-ogen) degradation products in Russell's viper (Daboia russelii siamensis) bite victims.
Han KE; Than T; Lwin M; Swe TN; Pe T
Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):198-201. PubMed ID: 8362297
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y
Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330
[TBL] [Abstract][Full Text] [Related]
25. Fibrinogen degradation products in acute renal failure of the newborn.
Assadi F; Delivoria-Papadopoulos M; Pereira G; Peckham G; Norman M
Clin Nephrol; 1983 Feb; 19(2):74-81. PubMed ID: 6839555
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of urinary fibrinogen degradation products in renal disease: study with two methods and correlation with histological findings of intraglomerular coagulation.
Loschiavo C; Previato G; Valvo E; Lupo A; Tessitore N; Chiaramonte S; Maschio G
Nephron; 1981; 28(4):200-3. PubMed ID: 7029322
[TBL] [Abstract][Full Text] [Related]
27. The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.
Shimoike T; Inoguchi T; Umeda F; Nawata H; Kawano K; Ochi H
Metabolism; 2000 Aug; 49(8):1030-5. PubMed ID: 10954022
[TBL] [Abstract][Full Text] [Related]
28. Urinary fibrin degradation products in childhood acute nephritis.
Dawson KP
N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
[TBL] [Abstract][Full Text] [Related]
29. [Assay of GBM antigen in urine and serum with an anti-human renal monoclonal antibody].
Mino Y
Nihon Jinzo Gakkai Shi; 1990 Apr; 32(4):365-72. PubMed ID: 2376909
[TBL] [Abstract][Full Text] [Related]
30. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
[TBL] [Abstract][Full Text] [Related]
31. Urinary fibrin and fibrinogen degradation products and the origin of hematuria.
Tsukahara H; Hiraoka M; Sudo M; Okada T; Morikawa K; Kuroda M
Acta Paediatr Jpn; 1992 Oct; 34(5):525-9. PubMed ID: 1442024
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
Bendel M; Oetliker O; Montandon A; Beck EA
Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
[TBL] [Abstract][Full Text] [Related]
33. Urinary fibrin/fibrinogen degradation product E (FDP-E) measured by a highly sensitive ELISA method in renal diseases.
Shibata T; Magari Y; Mizunaga S; Ishii T; Tomo T; Yasumori R; Nasu M; Taguchi T
Nephron; 1998 Aug; 79(4):494-5. PubMed ID: 9689177
[No Abstract] [Full Text] [Related]
34. [Origin of urinary FDP in children with renal diseases].
Yoshioka K; Iseki T; Ikeda H; Akano N; Uraoka Y; Miyata H; Maki S
Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):285-93. PubMed ID: 7120693
[No Abstract] [Full Text] [Related]
35. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
[TBL] [Abstract][Full Text] [Related]
36. [False positive FDP test associated with malignant lymphoma].
Kitazume K; Usuki K; Endo M; Osawa M; Iki S; Urabe A
Rinsho Ketsueki; 1997 Jan; 38(1):52-7. PubMed ID: 9028162
[TBL] [Abstract][Full Text] [Related]
37. Urine fibrin degradation products in detection and management of acute and chronic renal transplant rejection.
Cattran DC; Hockley M; Fenton SS; Wilson DR
Clin Nephrol; 1977 Jun; 7(6):255-61. PubMed ID: 326454
[TBL] [Abstract][Full Text] [Related]
38. Detection of urinary fibrin-fibrinogen degradation products in kidney transplantation.
Exaire E; Flores-Izquierdo G; Ortiz F; Pizzuto J; Cruz M; Gutiérrez ML
Arch Invest Med (Mex); 1978; 9(3):503-10. PubMed ID: 361009
[TBL] [Abstract][Full Text] [Related]
39. [Urinary excretion of fibrin degradation products in children with nephrotic syndrome (author's transl)].
Bouissou F; Barthe P; Boneu B
Arch Fr Pediatr; 1980 Mar; 37(3):167-71. PubMed ID: 7469695
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of latex agglutination tests for fibrin-fibrinogen degradation products in the forensic identification of menstrual blood.
Akutsu T; Watanabe K; Motani H; Iwase H; Sakurada K
Leg Med (Tokyo); 2012 Jan; 14(1):51-4. PubMed ID: 22189168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
